Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.18
-0.42 (-1.42%)
Jun 13, 2025, 4:00 PM - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 357 employees as of December 31, 2024. The number of employees increased by 160 or 81.22% compared to the previous year.
Employees
357
Change (1Y)
160
Growth (1Y)
81.22%
Revenue / Employee
$1,860,737
Profits / Employee
$122,952
Market Cap
937.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
COLL News
- 26 days ago - Collegium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Collegium Announces $25 Million Accelerated Share Repurchase Program - GlobeNewsWire
- 5 weeks ago - Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 7 weeks ago - Collegium to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 2 months ago - Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting - GlobeNewsWire
- 3 months ago - Collegium Announces Updates to its Board of Directors and Executive Leadership Team - GlobeNewsWire